CD133 expression is associated with poor outcome in neuroblastoma via chemoresistance mediated by the AKT pathway.
about
The PI3K/Akt Pathway in Tumors of Endocrine TissuesCancer Stem Cells and Their Interaction with the Tumor Microenvironment in NeuroblastomaValproic Acid Increases CD133 Positive Cells that Show Low Sensitivity to Cytostatics in NeuroblastomaTargeting Neuroblastoma Cell Surface Proteins: Recommendations for Homology Modeling of hNET, ALK, and TrkBProteome profiling of neuroblastoma-derived exosomes reveal the expression of proteins potentially involved in tumor progressionIterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations.A distinct gene expression signature characterizes human neuroblastoma cancer stem cells.Efficient Killing of High Risk Neuroblastoma Using Natural Killer Cells Activated by Plasmacytoid Dendritic Cells.Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cellsIn triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133high to CD133low phenotype and reduces the CD133-related invasivenessCD133+ cells contribute to radioresistance via altered regulation of DNA repair genes in human lung cancer cells.New prognostic markers in neuroblastoma.The role of the dysfunctional akt-related pathway in cancer: establishment and maintenance of a malignant cell phenotype, resistance to therapy, and future strategies for drug development.Cancer stem cells as therapeutic targets of hepato-biliary-pancreatic cancers.Neuroblastoma in children: Update on clinicopathologic and genetic prognostic factors.CD133 Modulate HIF-1α Expression under Hypoxia in EMT Phenotype Pancreatic Cancer Stem-Like Cells.Expression of CD133 in differentiated thyroid cancer of young patients.Differential effect of long-term drug selection with doxorubicin and vorinostat on neuroblastoma cells with cancer stem cell characteristicsp38MAPK inhibition: a new combined approach to reduce neuroblastoma resistance under etoposide treatment.Wnt pathway activity confers chemoresistance to cancer stem-like cells in a neuroblastoma cell line.Mapping sites of herpes simplex virus type 1 glycoprotein D that permit insertions and impact gD and gB receptors usage.HLA-DR expression on myeloid cells is a potential prognostic factor in patients with high-risk neuroblastoma.Neuroblastoma pathogenesis: deregulation of embryonic neural crest development.A phase I/Ib trial targeting the Pi3k/Akt pathway using perifosine: Long-term progression-free survival of patients with resistant neuroblastoma.Bone marrow-derived mesenchymal stem cells increase drug resistance in CD133-expressing gastric cancer cells by regulating the PI3K/AKT pathway.
P2860
Q26770404-17A9C753-B757-45C9-8A86-1512D01758C1Q26771238-37843D23-FEBA-4C57-84F4-6DC79C2C0769Q28554068-C1D5568B-AC51-4731-A44A-7AE78FBEA817Q28818744-4ED2E2E0-127B-43EE-91CE-9089DCAF6CFEQ34999444-6D5FB0EA-CA36-422A-AC07-414D7A1F227AQ36129189-3B1B3320-58DF-4CB3-8461-96927B766477Q36148130-2738422A-2A16-465E-88D3-7DF17070DA04Q36157777-7C840AC3-AAB8-4E17-96B5-476A59514235Q36799036-E7050266-ED5B-40ED-8ACF-B7A46EC3FF5FQ37399964-C5B4876B-4363-49BE-B6A2-8D8325577288Q37732341-149A8AF9-E80F-4355-8B02-3959283587D1Q38088418-DD4DACE0-EC1B-41F3-B08B-312AA2002CD3Q38175044-71821DB1-DCDC-464B-B834-D74E916D2895Q38421310-E0EC2A49-EA9A-4BA7-A4C8-3F24AFFD56C9Q38702196-0CEFFC05-6B4F-43C7-840A-95B50EFCCF8FQ38760452-63D4B69B-60BA-4E68-A4F0-0F34754A4EC8Q38900211-C30DA580-5E2E-43DB-9938-42BCB07CC6A8Q39120248-632D3E51-E9E9-4665-8DDB-8D957D542058Q39167686-6EC309C3-D2BC-402A-93CA-5915586927F9Q39298930-E63213E5-E081-45DE-AF1B-98F6EA388AD6Q40310537-1B7726B6-B22C-40F9-81D6-E0C6AD8D7A56Q42829235-BCCDD877-F609-4DCC-9A99-FA295FC10FD3Q45875651-61E60E5D-EED0-4503-9AAA-9595851066DAQ51483438-C005FC54-7697-4C4F-A128-EF44A622ACAEQ51516469-016B27FC-DB15-4A6F-B4E7-623A4C7FA668
P2860
CD133 expression is associated with poor outcome in neuroblastoma via chemoresistance mediated by the AKT pathway.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
CD133 expression is associated ...... e mediated by the AKT pathway.
@en
CD133 expression is associated ...... e mediated by the AKT pathway.
@nl
type
label
CD133 expression is associated ...... e mediated by the AKT pathway.
@en
CD133 expression is associated ...... e mediated by the AKT pathway.
@nl
prefLabel
CD133 expression is associated ...... e mediated by the AKT pathway.
@en
CD133 expression is associated ...... e mediated by the AKT pathway.
@nl
P2093
P2860
P1433
P1476
CD133 expression is associated ...... e mediated by the AKT pathway.
@en
P2093
Borhane Annabi
Carine Nyalendo
Gilles Vassal
Hervé Sartelet
Kokta Victor
Lubo Alexendrov
Michel Duval
Monique Fabre
Raouf Fetni
Tina Imbriglio
P2860
P304
P356
10.1111/J.1365-2559.2012.04191.X
P577
2012-03-06T00:00:00Z